The FDA has opened the door to the use of Bayesian statistical methods in clinical trials. The worry: Introducing ...
The guidance encourages the use of Bayesian statistics in drug trials. Instead of starting from scratch and only adding new ...
WASHINGTON, Jan. 20, 2026 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has issued new draft guidance modernizing statistical methodologies used in clinical trials, formally recognizing ...
Ideally, specific treatment for a cancer patient is decided by a multidisciplinary tumor board, integrating prior clinical experience, published data, and patient-specific factors to develop a ...